JPRN-UMIN000018743已完成未知
Evaluation of silodosin versus tadalafil in patients with urination disorders associated with benign prostatic hyperplasia - Evaluation of silodosin versus tadalafil in patients with urination disorders associated with benign prostatic hyperplasia
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Patients have any of the contraindications listed in the package inserts for silodosin or tadalafil. 2) Patients have prostate cancer. 3) Patients have lower urinary tract symptoms possibly due to urinary tract infection or neurogenic bladder. 4) Patients have used silodosin or tadalafil within 12 weeks prior to Week 0.
研究者
相似试验
已完成
不适用
Silodosin, Tadalafil Alone vs. Silodosin Plus Tadalafil as MET for Lower Ureteric StonesLower Ureteric StonesMedical Expulsive TherapyTadalafilSilodosinNCT05789732Benha University168
已完成
2 期
Tadalafil and the recurrence of acute urinary retentioPACTR202305669258195oghmari Ahmed48
尚未招募
不适用
COMPARISION OF EFFICACY OF SILODOSIN VERSUS TADALAFIL IN PATIENTS WITH LOWER URINARY TRACT SYMPTOMS ( LIKE FREQUENCY, URGENCY, URGE INCONTINENCE, NOCTURIA, POOR STREAM OF URINE, STRAINING TO VOID,ETC ) ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA ( A NON MALIGNANT ENLARGEMENT OF PROSTATE GLAND )CTRI/2019/05/019342Dr Mapranathukaran Devassy Robin
已完成
2 期
Comparison of Sildenafil and Tadalafil in the treatment of benign prostatic hyperplasiaBenign prostatic hyperplasia (BPH).Enlarged prostate with lower urinary tract symptomsN40.1IRCT20210925052576N1Islamic Azad University66
Unknown
不适用
Safety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic HyperplasiaSafety and Efficacy of Tadalafil vs. Tadalafil With Sildosin in the Management of Moderately and Severely Symptomatic Patients of Prostatic HyperplasiaNCT04577040Menoufia University400